SureTrader Advertisement Advertisement
Home > Boards > US Listed > Biotechs >

Inovio Pharmaceuticals, Inc. (INO)

Add INO Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator biovalidator, TomP1
Search This Board:
Last Post: 11/13/2015 7:25:33 PM - Followers: 401 - Board type: Free - Posts Today: 0

Logo: Inovio

ebruary 12, 2014 Inovio CEO Dr. Joseph Kim rings bell to open trading on NYSE-

Float: 97.65 M

Shares Outstanding: 127.26 M

Inovio Biomedical Corporation engages in the design, development, and delivery of a new generation of vaccines, called DNA vaccines, focused on cancers and infectious diseases. The company?s SynCon technology enables the design of DNA-based vaccines capable of providing cross-protection against evolving, unmatched strains of pathogens, such as influenza. Inovio?s proprietary electroporation DNA delivery technology uses brief, controlled electrical pulses to increase cellular DNA vaccine uptake. The company also has access to formulation and manufacturing expertise, and technology through its controlling ownership in VGX International. Inovio?s clinical programs include trials for HPV/cervical cancer (therapeutic) and HIV vaccines; and an IND has been filed for an avian influenza vaccine. Its partners and collaborators include Roche,Merck, Tripep, University of Southampton, University of Pennsylvania, HIV Vaccines Trial Network, and National Microbiology Laboratory of the Public Health Agency of Canada. The company was formerly known as Genetronics Biomedical Corp. and changed its name to Inovio Biomedical Corporation in March 2005. The company was founded in 1983 and is based in San Diego, California.

Currently Inovio has 12 clinical studies ( HIV, Influenza, Malaria, Hepatitis B, Hepatitis C, Breast and Lung cancer, Prostate Cancer, Head and Neck cancer, Cervical Cancer, Cervical dysplasia caused by HPV) ongoing from preclinical to phase 2.
Sep 10, 2013
Roche and Inovio Pharmaceuticals partner on Inovio's prostate cancer and hepatitis B immunotherapy products. Roche will make an upfront payment of USD $10 million to Inovio. Roche will also provide preclinical R&D support and payments for near-term regulatory milestones as well as payments upon reaching certain development and commercial milestones potentially up to USD $412.5 million. Additional development milestone payments could also be made to Inovio if Roche pursues other indications with INO-5150 or INO-1800.  In addition, Inovio is entitled to receive up to double-digit tiered royalties on product sales.

VGX-3100-Phase 2 Clinical Trial initiated for the treatment Cervical dysplasia (cervical intraepithelial neoplasia or CIN) caused by HPV
Top line data release Mid 2014
May 13, 2014:  Inovio Pharmaceuticals Acquires Early Stage DNA Therapies to Treat Alzheimer's and Multiple Sclerosis

May 23, 2014: Inovio Pharmaceuticals Announces 1 For 4 Reverse Split
1-for-4 reverse stock split shall become effective at 5 P.M., Thursday, June 5, 2014, and trading of the Company's common stock on a post-reverse split basis shall commence on Friday, June 6, 2014.

Inovio’s goal is to revolutionize vaccines. With best-in-class immune responses from multiple vaccines in different disease areas, our synthetic vaccine technology is making big strides toward this important goal.



  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
#4698  Sticky Note Please stay on topic. The only topic to IH Admin [Dan] 08/02/13 01:15:33 PM
#13150   Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Stock PT Range: $17-$31 nanopatent 11/13/15 07:25:33 PM
#13149   Take note of these subtleties nanopatent 11/12/15 02:44:58 PM
#13148   hello all, still here with a core position. harry crumb 11/11/15 10:43:10 PM
#13147   3% on the way to 100%!? nanopatent 11/05/15 10:21:18 AM
#13146   Well, nearly 3% beaten anyway. swingingRichard 11/05/15 10:16:44 AM
#13145   Cool! Sorry TomP1 11/05/15 09:23:39 AM
#13144   Please - no sarcasm intended. nanopatent 11/05/15 09:17:47 AM
#13143   VGX-3100 is the first therapy to demonstrate that nanopatent 11/05/15 09:13:56 AM
#13142   I'll take as a sarcastic remark. Rome wasnt build TomP1 11/05/15 09:12:53 AM
#13141   Cancer beaten! nanopatent 11/05/15 09:11:43 AM
#13140 TomP1 11/05/15 08:21:10 AM
#13139   The meeting are today and tomorrow. But the biovalidator 10/22/15 08:45:06 AM
#13138   Maybe he did go to the Naval observatory ;) TomP1 10/22/15 07:53:03 AM
#13137   Did Dr. Kim go to White House Monday? north40000 10/21/15 01:15:23 PM
#13136   Dr. Kim is in Washington DC this week biovalidator 10/20/15 09:02:47 PM
#13135   the near term catalyst is MERS. US quannah 10/20/15 04:36:03 PM
#13134   INO double in 2016 nanopatent 10/20/15 03:04:17 PM
#13133   Sold some of my INO shares this morning ppnlf 10/15/15 04:15:16 PM
#13132   when the science gets closer to completion. patience, harry crumb 10/06/15 09:21:43 PM
#13131   Isn't that always the case? Lol billmick11 10/06/15 06:20:08 PM
#13130   When the shorts get tired of beating on it. kpisme 10/06/15 05:14:04 PM
#13129   I kinda lost track of INO since it billmick11 10/06/15 04:54:33 PM
#13128   added more today! sit an wait now. harry crumb 10/01/15 11:52:59 AM
#13127   9/30 Form 4 - Sardesai bought 4K @ fireopal 09/30/15 05:24:18 PM
#13126   It's loadup time! TomP1 09/30/15 01:44:54 PM
#13125   .....stands for We are Totally F'd??? (At least it seems ppnlf 09/30/15 12:53:30 PM
#13124   WTF? SABAI 09/30/15 11:48:17 AM
#13123   Questions When INO is making $10 a share what nanopatent 09/28/15 02:04:16 PM
#13122   All it shows is that the market knows TomP1 09/28/15 11:21:08 AM
#13121   As we now seem to be heading back ppnlf 09/28/15 10:21:30 AM
#13120   Agree, but will get some love soon (the ringao 09/21/15 07:35:11 PM
#13119   INO is out of love, period Also, this is TomP1 09/21/15 02:06:40 PM
#13118   Cant believe this isn't moving price up CCruzNY 09/21/15 01:56:05 PM
#13117   Inovio Receives $24 Million Option Grant from DARPA nanopatent 09/21/15 10:26:13 AM
#13116   Guys, I hope you appreciate how big the pmgtrader 09/17/15 06:06:51 PM
#13115   What I think has very little correlation with TomP1 09/17/15 09:30:49 AM
#13114   Think big. nanopatent 09/17/15 09:29:10 AM
#13113   No, no way, sorry TomP1 09/17/15 09:27:44 AM
#13112   Surely good news but keep your pps targets TomP1 09/17/15 09:27:18 AM
#13111   Can Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Touch $31? nanopatent 09/17/15 09:21:09 AM
#13110   This guarantees double figures: nanopatent 09/17/15 08:45:53 AM
#13109   Looking to jump into this puppy in next brandao 09/15/15 07:04:25 AM
#13108   Inovio Slide deck presentation from this week talks biovalidator 09/11/15 12:25:09 PM
#13107   Inovio Pharmaceuticals Announces First Patient Dosed With Universal biovalidator 09/08/15 12:12:33 PM
#13106   Heavy volume into close. News in the AM perhaps? Perkin78 09/02/15 05:40:22 PM
#13105   Nice find! TomP1 09/02/15 11:49:02 AM
#13104   Inovio is presenting at MERs conference in Korea biovalidator 09/02/15 10:02:18 AM
#13103   Yes, aria massive short covering! Ino next!! harry crumb 08/28/15 02:50:07 PM
#13102   Gotta have some patience, we are still below TomP1 08/28/15 02:41:03 PM
#13101   Not only "10" but 10 to the 10th nanopatent 08/28/15 02:35:38 PM